(Q42910001)

English

Efficacy of tyrosine kinase inhibitors (TKIs) as third-line therapy in patients with chronic myeloid leukemia in chronic phase who have failed 2 prior lines of TKI therapy.

scientific article published on 10 September 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Efficacy of tyrosine kinase inhibitors (TKIs) as third-line therapy in patients with chronic myeloid leukemia in chronic phase who have failed 2 prior lines of TKI therapy (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6143154&resulttype=core&format=json

12 May 2020

chronic myeloid leukemia

0 references

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6143154&resulttype=core&format=json

12 May 2020

Francesco Dazzi

11

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6143154&resulttype=core&format=json

12 May 2020

author name string

Amr R Ibrahim

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6143154&resulttype=core&format=json

12 May 2020

Christos Paliompeis

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6143154&resulttype=core&format=json

12 May 2020

Marco Bua

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6143154&resulttype=core&format=json

12 May 2020

Dragana Milojkovic

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6143154&resulttype=core&format=json

12 May 2020

Jamshid S Khorashad

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6143154&resulttype=core&format=json

12 May 2020

Letizia Foroni

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6143154&resulttype=core&format=json

12 May 2020

Alistair Reid

8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6143154&resulttype=core&format=json

12 May 2020

Hugues de Lavallade

9

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6143154&resulttype=core&format=json

12 May 2020

Katayoun Rezvani

10

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6143154&resulttype=core&format=json

12 May 2020

Jane F Apperley

12

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6143154&resulttype=core&format=json

12 May 2020

John M Goldman

13

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6143154&resulttype=core&format=json

12 May 2020

David Marin

14

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6143154&resulttype=core&format=json

12 May 2020

language of work or name

0 references

publication date

10 September 2010

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6143154&resulttype=core&format=json

12 May 2020

116

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6143154&resulttype=core&format=json

12 May 2020

25

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6143154&resulttype=core&format=json

12 May 2020

5497-5500

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6143154&resulttype=core&format=json

12 May 2020

Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias

1 reference

https://pubmed.ncbi.nlm.nih.gov/20833982

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intermittent target inhibition with dasatinib 100 mg once daily preserves efficacy and improves tolerability in imatinib-resistant and -intolerant chronic-phase chronic myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20833982

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Part II: management of resistance to imatinib in chronic myeloid leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20833982

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early prediction of success or failure of treatment with second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20833982

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors for patients with chronic myeloid leukaemia in chronic phase treated with imatinib mesylate after failure of interferon alfa

1 reference

https://pubmed.ncbi.nlm.nih.gov/20833982

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20833982

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dasatinib induces notable hematologic and cytogenetic responses in chronic-phase chronic myeloid leukemia after failure of imatinib therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20833982

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of nilotinib or dasatinib after failure to 2 prior tyrosine kinase inhibitors: long-term follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/20833982

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance

1 reference

https://pubmed.ncbi.nlm.nih.gov/20833982

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL

1 reference

https://pubmed.ncbi.nlm.nih.gov/20833982

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imatinib for newly diagnosed patients with chronic myeloid leukemia: incidence of sustained responses in an intention-to-treat analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20833982

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20833982

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1182/BLOOD-2010-06-291922

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6143154&resulttype=core&format=json

12 May 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6143154&resulttype=core&format=json

12 May 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6143154&resulttype=core&format=json

12 May 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42910001&oldid=1582765736"